PREPARE-IT 1: Icosapent Ethyl Does Not Reduce SARS-CoV-2 Infection Rate vs. Placebo
A 2-month regimen of icosapent ethyl did not prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people who had not previously been infected or vaccinated against the virus, according to new trial results presented Sunday.